The role of liver biopsy in chronic hepatitis C

Hepatology

Volumn 33, Issue 1, 2001, Pages 196-200

  Saadeh, Sherif ^a   Cammell, Greg ^a   Carey, William D ^a   Younossi, Zobair ^a   Barnes, David ^a   Easley, Kirk ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONICITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 0035192821     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.20534     Document Type: Article

References (28)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
2. Hepatitis C update
3. Hepatitis C: An update on the silent epidemic
4. Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications
5. Hepatitis C: Advances in diagnosis
6. Therapy for chronic hepatitis C
7. Serologic tests for HCV infection
8. Histopathology of hepatitis C infection
9. To C or not to C: These are the questions
10. Hepatitis C RNA levels determined by branched chain DNA probe assay correlated with levels assessed using competitive PCR
11. The role of liver biopsy in hepatitis C
12. Is an "a la carte" combination interferon alpha-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
13. Natural history of liver fibrosis progression in patients with Chronic hepatitis C
14. Comparative efficacy of interferon alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis
15. Liver biopsy in the mid-1990's: Questions and answers
16. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection
17. Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C
18. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis
19. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
20. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
21. 45-Year follow-up of hepatitis C virus infection in healthy young adults
22. Natural history of hepatitis C
23. The long-term pathological evolution of chronic hepatitis C
24. Long term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: Morphometric analysis of repeated biopsies
25. The utility of liver biopsy in diagnosis of hepatitis C (HCV)
26. Liver biopsy: Review of methodology and complications
27. Liver biopsy: Complications in 1000 inpatients and outpatients
28. Outcome of patients hospitalized for complications after outpatient liver biopsy